BOTTA, MARGHERITA
BOTTA, MARGHERITA
Dipartimento di Scienze Farmacologiche e Biomolecolari
PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor
2019 L. Da Dalt, M. Ruscica, F. Bonacina, G. Balzarotti, A. Dhyani, E. Di Cairano, A. Baragetti, L. Arnaboldi, S. De Metrio, F. Pellegatta, L. Grigore, M. Botta, C. Macchi, P. Uboldi, C. Perego, A.L. Catapano, G.D. Norata
DECIPHERING THE ROLE OF ADIPOKINES ON PCSK9 REGULATION: EXPERIMENTAL EVIDENCE
2019 M. Botta
Deciphering the role of V200A and N291S mutations leading to LPL deficiency
2019 M. Botta, E. Maurer, M. Ruscica, S. Romeo, T.M. Stulnig, P. Pingitore
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract : results from a randomized, double-blind, placebo-controlled study
2019 M. Ruscica, C. Pavanello, S. Gandini, C. Macchi, M. Botta, D. Dall’Orto, M. Del Puppo, M. Bertolotti, R. Bosisio, G. Mombelli, C.R. Sirtori, L. Calabresi, P. Magni
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation
2018 M. Ruscica, M. Botta, N. Ferri, E. Giorgio, C. Macchi, G. Franceschini, P. Magni, L. Calabresi, M. Gomaraschi
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders
2018 M. Ruscica, S. Simonelli, M. Botta, A. Ossoli, M.G. Lupo, P. Magni, A. Corsini, M. Arca, L. Pisciotta, F. Veglia, G. Franceschini, N. Ferri, L. Calabresi
PPAR Agonists and Metabolic Syndrome : An Established Role?
2018 M. Botta, M. Audano, A. Sahebkar, C. Sirtori, N. Mitro, M. Ruscica
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients
2018 M.G. Zenti, A. Altomari, M.G. Lupo, M. Botta, E. Bonora, A. Corsini, M. Ruscica, N. Ferri
Influence of body variables in the development of metabolic syndrome : A long term follow-up study
2018 C. Pavanello, A.M. Zanaboni, S. Gaito, M. Botta, G. Mombelli, C.R. Sirtori, M. Ruscica
Body composition and metabolic changes during a 520-day mission simulation to Mars
2018 F. Strollo, C. Macchi, I. Eberini, M.A. Masini, M. Botta, G. Vassilieva, I. Nichiporuk, M. Monici, D. Santucci, F. Celotti, P. Magni, M. Ruscica
PCSK9, SINDROME METABOLICA E DIABETE
2017 N. Ferri, C. Macchi, M. Botta, S. Marchianò, C.R. Sirtori, A. Corsini, M. Ruscica
Pro-inflammatory cytokines and adipokines regulate PCSK9 expression in HepG2 cells
2017 M. Ruscica, M. Botta, M. Garzone, C. Macchi, S. Marchiano, A. Corsini, P. Magni, N. Ferri
Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study
2017 M. Ruscica, N. Ferri, F. Fogacci, M. Rosticci, M. Botta, S. Marchiano, P. Magni, S. D'Addato, M. Giovannini, C. Borghi, A.F.G. Cicero
High density lipoproteins inhibit oxidative stress-induced prostate cancer cell proliferation
2016 M. Ruscica, M. Botta, N. Ferri, C. Songia, G. Franceschini, L. Calabresi, P. Magni, M. Gomaraschi
PCSK9 expression is regulated by pro-inflammatory cytokines and adipokines in HEPG2 cells
2016 M. Botta, C. Songia, C. Macchi, N. Ferri, A. Corsini, P. Magni, M. Ruscica
Decellularized biological matrices : an interesting approach for cardiovascular tissue repair and regeneration
2015 F. Boccafoschi, M. Botta, L. Fusaro, F. Copes, M. Ramella, M. Cannas
Arginine-glycine-glutamine and serine-isoleucine-lysine-valine-alanine-valine modified poly(l-lactide) films : bioactive molecules used for surface grafting to guide cellular contractile phenotype
2014 F. Boccafoschi, L. Fusaro, M. Botta, M. Ramella, P. Chevallier, D. Mantovani, M. Cannas